{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:29:08Z","timestamp":1793946548818,"version":"4.8.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T00:00:00Z","timestamp":1372118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T00:00:00Z","timestamp":1372118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11481-013-9484-2","type":"journal-article","created":{"date-parts":[[2013,6,24]],"date-time":"2013-06-24T00:37:11Z","timestamp":1372034231000},"page":"69-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases"],"prefix":"10.1007","volume":"9","author":[{"given":"Carl-Henrik","family":"Heldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,25]]},"reference":[{"issue":"6","key":"9484_CR1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20041393","volume":"201","author":"A Abdollahi","year":"2005","unstructured":"Abdollahi A, Li M, Ping G, Plathow C, Domhan S, Kiessling F, Lee LB, McMahon G, Grone HJ, Lipson KE et al (2005) Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201(6):925\u2013935","journal-title":"J Exp Med"},{"issue":"6","key":"9484_CR2","doi-asserted-by":"crossref","first-page":"e38760","DOI":"10.1371\/journal.pone.0038760","volume":"7","author":"MB Abrams","year":"2012","unstructured":"Abrams MB, Nilsson I, Lewandowski SA, Kjell J, Codeluppi S, Olson L, Eriksson U (2012) Imatinib enhances functional outcome after spinal cord injury. PLoS One 7(6):e38760","journal-title":"PLoS One"},{"issue":"7","key":"9484_CR3","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1096\/fj.07-105627","volume":"22","author":"A Akhmetshina","year":"2008","unstructured":"Akhmetshina A, Dees C, Pileckyte M, Maurer B, Axmann R, Jungel A, Zwerina J, Gay S, Schett G, Distler O et al (2008) Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J 22(7):2214\u20132222","journal-title":"FASEB J"},{"issue":"1","key":"9484_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/art.24186","volume":"60","author":"A Akhmetshina","year":"2009","unstructured":"Akhmetshina A, Venalis P, Dees C, Busch N, Zwerina J, Schett G, Distler O, Distler JH (2009) Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum 60(1):219\u2013224","journal-title":"Arthritis Rheum"},{"issue":"23","key":"9484_CR5","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/CIRCULATIONAHA.112.134304","volume":"126","author":"J Aman","year":"2012","unstructured":"Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa EC, Vogel SM, Groeneveld AB, Vonk Noordegraaf A, van Hinsbergh VW, van Nieuw Amerongen GP (2012) Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation 126(23):2728\u20132738","journal-title":"Circulation"},{"issue":"10","key":"9484_CR6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","volume":"22","author":"J Andrae","year":"2008","unstructured":"Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276\u20131312","journal-title":"Genes Dev"},{"issue":"11","key":"9484_CR7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1517\/14728222.2012.719500","volume":"16","author":"SA Antoniu","year":"2012","unstructured":"Antoniu SA (2012) Targeting PDGF pathway in pulmonary arterial hypertension. Expert Opin Ther Targets 16(11):1055\u20131063","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"9484_CR8","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0006-2952(93)90675-M","volume":"46","author":"SS Arcot","year":"1993","unstructured":"Arcot SS, Lipke DW, Gillespie MN, Olson JW (1993) Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem Pharmacol 46(6):1086\u20131091","journal-title":"Biochem Pharmacol"},{"issue":"7323","key":"9484_CR9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature09522","volume":"468","author":"A Armulik","year":"2010","unstructured":"Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K et al (2010) Pericytes regulate the blood\u2013brain barrier. Nature 468(7323):557\u2013561","journal-title":"Nature"},{"issue":"7","key":"9484_CR10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/ard.2007.085480","volume":"67","author":"E Balada","year":"2008","unstructured":"Balada E, Simeon-Aznar CP, Ordi-Ros J, Rosa-Leyva M, Selva-O\u2019Callaghan A, Pardos-Gea J, Fonollosa-Pla V, Vilardell-Tarres M (2008) Anti-PDGFR-\u03b1 antibodies measured by non-bioactivity assays are not specific for systemic sclerosis. Ann Rheum Dis 67(7):1027\u20131029","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9484_CR11","doi-asserted-by":"crossref","first-page":"L826","DOI":"10.1152\/ajplung.00199.2002","volume":"284","author":"V Balasubramaniam","year":"2003","unstructured":"Balasubramaniam V, Le Cras TD, Ivy DD, Grover TR, Kinsella JP, Abman SH (2003) Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284(5):L826\u2013L833","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"19","key":"9484_CR12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.97.19.1960","volume":"97","author":"S Banai","year":"1998","unstructured":"Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R et al (1998) PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 97(19):1960\u20131969","journal-title":"Circulation"},{"issue":"1","key":"9484_CR13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V99.1.381","volume":"99","author":"C Beham-Schmid","year":"2002","unstructured":"Beham-Schmid C, Apfelbeck U, Sill H, Tsybrovsky O, Hofler G, Haas OA, Linkesch W (2002) Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis. Blood 99(1):381\u2013383","journal-title":"Blood"},{"issue":"4","key":"9484_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","volume":"15","author":"JC Bonner","year":"2004","unstructured":"Bonner JC (2004) Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15(4):255\u2013273","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"9484_CR15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/ndt\/gfl691","volume":"22","author":"P Boor","year":"2007","unstructured":"Boor P, Konieczny A, Villa L, Kunter U, van Roeyen CR, LaRochelle WJ, Smithson G, Arrol S, Ostendorf T, Floege J (2007) PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 22(5):1323\u20131331","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"9484_CR16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jhep.2007.01.029","volume":"46","author":"E Borkham-Kamphorst","year":"2007","unstructured":"Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R (2007) Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 46(6):1064\u20131074","journal-title":"J Hepatol"},{"issue":"6","key":"9484_CR17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0092-8674(00)81270-2","volume":"85","author":"H Bostr\u00f6m","year":"1996","unstructured":"Bostr\u00f6m H, Willetts K, Pekny M, Lev\u00e9en P, Lindahl P, Hedstrand H, Pekna M, Hellstr\u00f6m M, Gebre-Medhin S, Schalling M et al (1996) PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85(6):863\u2013873","journal-title":"Cell"},{"issue":"5617","key":"9484_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1082095","volume":"300","author":"P Boucher","year":"2003","unstructured":"Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300(5617):329\u2013332","journal-title":"Science"},{"issue":"2","key":"9484_CR19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cncr.20380","volume":"101","author":"CE Bueso-Ramos","year":"2004","unstructured":"Bueso-Ramos CE, Cortes J, Talpaz M, O\u2019Brien S, Giles F, Rios MB, Medeiros LJ, Kantarjian H (2004) Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia. Cancer 101(2):332\u2013336","journal-title":"Cancer"},{"issue":"3","key":"9484_CR20","first-page":"152","volume":"11","author":"Y Cai","year":"1996","unstructured":"Cai Y, Han M, Luo L, Song W, Zhou X (1996) Increased expression of PDGF and c-myc genes in lungs and pulmonary arteries of pulmonary hypertensive rats induced by hypoxia. Chin Med Sci J 11(3):152\u2013156","journal-title":"Chin Med Sci J"},{"issue":"5","key":"9484_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0896-6273(00)80469-9","volume":"20","author":"AR Calver","year":"1998","unstructured":"Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD (1998) Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20(5):869\u2013882","journal-title":"Neuron"},{"issue":"9","key":"9484_CR22","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.0409722102","volume":"102","author":"JS Campbell","year":"2005","unstructured":"Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS et al (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102(9):3389\u20133394","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9484_CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.ajkd.2008.08.029","volume":"53","author":"S Chandran","year":"2009","unstructured":"Chandran S, Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA (2009) Imatinib in the treatment of nephrogenic systemic fibrosis. Am J Kidney Dis 53(1):129\u2013132","journal-title":"Am J Kidney Dis"},{"issue":"7369","key":"9484_CR24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature10502","volume":"478","author":"H Chen","year":"2011","unstructured":"Chen H, Gu X, Liu Y, Wang J, Wirt SE, Bottino R, Schorle H, Sage J, Kim SK (2011a) PDGF signalling controls age-dependent proliferation in pancreatic \u03b2-cells. Nature 478(7369):349\u2013355","journal-title":"Nature"},{"issue":"11","key":"9484_CR25","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ki.2011.208","volume":"80","author":"YT Chen","year":"2011","unstructured":"Chen YT, Chang FC, Wu CF, Chou YH, Hsu HL, Chiang WC, Shen J, Chen YM, Wu KD, Tsai TJ et al (2011b) Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 80(11):1170\u20131181","journal-title":"Kidney Int"},{"issue":"2","key":"9484_CR26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.24221","volume":"60","author":"L Chung","year":"2009","unstructured":"Chung L, Fiorentino DF, Benbarak MJ, Adler AS, Mariano MM, Paniagua RT, Milano A, Connolly MK, Ratiner BD, Wiskocil RL et al (2009) Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 60(2):584\u2013591","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9484_CR27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/art.24381","volume":"60","author":"J-F Classen","year":"2009","unstructured":"Classen J-F, Henrohn D, Rorsman F, Lennartsson J, Lauwerys BR, Wikstr\u00f6m G, Rorsman C, Lenglez S, Franck-Larsson K, Tomasi J-P et al (2009) Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 60(4):1137\u20131144","journal-title":"Arthritis Rheum"},{"issue":"3","key":"9484_CR28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","volume":"45","author":"P Czochra","year":"2006","unstructured":"Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW et al (2006) Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45(3):419\u2013428","journal-title":"J Hepatol"},{"issue":"2","key":"9484_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/2045-8932.83448","volume":"1","author":"BK Dahal","year":"2011","unstructured":"Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F, Schermuly RT (2011) Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-\u03b2. Pulm Circ 1(2):259\u2013268","journal-title":"Pulm Circ"},{"issue":"7","key":"9484_CR30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2010.493559","volume":"20","author":"Y Dai","year":"2010","unstructured":"Dai Y (2010) Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature. Expert Opin Ther Pat 20(7):885\u2013897","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"9484_CR31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","volume":"181","author":"CE Daniels","year":"2010","unstructured":"Daniels CE, Lasky JA, Limper AH, Mieras K, Gabor E, Schroeder DR (2010) Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med 181(6):604\u2013610","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"9484_CR32","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger M, Buchdunger E, Druker BJ (2005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105(7):2640\u20132653","journal-title":"Blood"},{"issue":"Suppl 1","key":"9484_CR33","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/j.seminoncol.2011.01.018","volume":"38","author":"GD Demetri","year":"2011","unstructured":"Demetri GD (2011) Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. Semin Oncol 38(Suppl 1):S10\u2013S19","journal-title":"Semin Oncol"},{"issue":"10","key":"9484_CR34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm929","volume":"9","author":"G Di Pasquale","year":"2003","unstructured":"Di Pasquale G, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A, Chiorini JA (2003) Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med 9(10):1306\u20131312","journal-title":"Nat Med"},{"issue":"10","key":"9484_CR35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng1415","volume":"36","author":"H Ding","year":"2004","unstructured":"Ding H, Wu X, Bostrom H, Kim I, Wong N, Tsoi B, O\u2019Rourke M, Koh GY, Soriano P, Betsholtz C et al (2004) A specific requirement for PDGF-C in palate formation and PDGFR-\u03b1 signaling. Nat Genet 36(10):1111\u20131116","journal-title":"Nat Genet"},{"issue":"1","key":"9484_CR36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","volume":"56","author":"JH Distler","year":"2007","unstructured":"Distler JH, Jungel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S et al (2007) Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum 56(1):311\u2013322","journal-title":"Arthritis Rheum"},{"issue":"8","key":"9484_CR37","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/art.23694","volume":"58","author":"JH Distler","year":"2008","unstructured":"Distler JH, Manger B, Spriewald BM, Schett G, Distler O (2008) Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease. Arthritis Rheum 58(8):2538\u20132542","journal-title":"Arthritis Rheum"},{"issue":"14","key":"9484_CR38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S et al (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344(14):1031\u20131037","journal-title":"N Engl J Med"},{"issue":"1","key":"9484_CR39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1183\/09031936.00154210","volume":"38","author":"D Dumitrescu","year":"2011","unstructured":"Dumitrescu D, Seck C, ten Freyhaus H, Gerhardt F, Erdmann E, Rosenkranz S (2011) Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J 38(1):218\u2013220","journal-title":"Eur Respir J"},{"issue":"1","key":"9484_CR40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.expneurol.2003.11.001","volume":"186","author":"T Egawa-Tsuzuki","year":"2004","unstructured":"Egawa-Tsuzuki T, Ohno M, Tanaka N, Takeuchi Y, Uramoto H, Faigle R, Funa K, Ishii Y, Sasahara M (2004) The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol 186(1):89\u201398","journal-title":"Exp Neurol"},{"issue":"2","key":"9484_CR41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.2007030290","volume":"19","author":"F Eitner","year":"2008","unstructured":"Eitner F, Bucher E, van Roeyen C, Kunter U, Rong S, Seikrit C, Villa L, Boor P, Fredriksson L, Backstrom G et al (2008) PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 19(2):281\u2013289","journal-title":"J Am Soc Nephrol"},{"key":"9484_CR42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1653454","volume":"253","author":"GA Ferns","year":"1991","unstructured":"Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R (1991) Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253:1129\u20131132","journal-title":"Science"},{"issue":"1","key":"9484_CR43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0002-9440(10)65263-7","volume":"154","author":"J Floege","year":"1999","unstructured":"Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjic N (1999) Novel approach to specific growth factor inhibition in vivo. Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 154(1):169\u2013179","journal-title":"Am J Pathol"},{"issue":"1","key":"9484_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","volume":"19","author":"J Floege","year":"2008","unstructured":"Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19(1):12\u201323","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"9484_CR45","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1038\/sj.emboj.7600397","volume":"23","author":"L Fredriksson","year":"2004","unstructured":"Fredriksson L, Li H, Fieber C, Li X, Eriksson U (2004) Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 23(19):3793\u20133802","journal-title":"EMBO J"},{"issue":"3","key":"9484_CR46","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ajpath.2011.12.006","volume":"180","author":"L Fredriksson","year":"2012","unstructured":"Fredriksson L, Nilsson I, Su EJ, Andrae J, Ding H, Betsholtz C, Eriksson U, Lawrence DA (2012) Platelet-derived growth factor C deficiency in C57BL\/6 mice leads to abnormal cerebral vascularization, loss of neuroependymal integrity, and ventricular abnormalities. Am J Pathol 180(3):1136\u20131144","journal-title":"Am J Pathol"},{"issue":"6","key":"9484_CR47","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134(6):1655\u20131669","journal-title":"Gastroenterology"},{"key":"9484_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","volume":"92","author":"S Gay","year":"1989","unstructured":"Gay S, Jones REJ, Huang GQ, Gay RE (1989) Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 92:301\u2013303","journal-title":"J Invest Dermatol"},{"issue":"6","key":"9484_CR49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163\u20131177","journal-title":"J Cell Biol"},{"issue":"9","key":"9484_CR50","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","volume":"182","author":"HA Ghofrani","year":"2010","unstructured":"Ghofrani HA, Morrell NW, Hoeper MM, Olschewski H, Peacock AJ, Barst RJ, Shapiro S, Golpon H, Toshner M, Grimminger F et al (2010) Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med 182(9):1171\u20131177","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"9484_CR51","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.ATV.19.4.900","volume":"19","author":"NA Giese","year":"1999","unstructured":"Giese NA, Marijianowski MMH, McCook O, Hancock A, Ramakrishnan V, Fretto LJ, Chen C, Kelly AB, Koziol JA, Wilcox JN et al (1999) The role of \u03b1 and \u03b2 platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vasc Biol 19(4):900\u2013909","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"9484_CR52","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","volume":"59","author":"RE Gilbert","year":"2001","unstructured":"Gilbert RE, Kelly DJ, McKay T, Chadban S, Hill PA, Cooper ME, Atkins RC, Nikolic-Paterson DJ (2001) PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int 59(4):1324\u20131332","journal-title":"Kidney Int"},{"issue":"6","key":"9484_CR53","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/BOR.0b013e32833f1105","volume":"22","author":"JK Gordon","year":"2010","unstructured":"Gordon JK, Spiera RF (2010) Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis. Curr Opin Rheumatol 22(6):690\u2013695","journal-title":"Curr Opin Rheumatol"},{"issue":"45","key":"9484_CR54","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1021\/bi961544+","volume":"35","author":"LS Green","year":"1996","unstructured":"Green LS, Jellinek D, Jenison R, \u00d6stman A, Heldin C-H, Janjic N (1996) Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35(45):14413\u201314424","journal-title":"Biochemistry"},{"issue":"16","key":"9484_CR55","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695","journal-title":"N Engl J Med"},{"issue":"4","key":"9484_CR56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.99.4.564","volume":"99","author":"CE Hart","year":"1999","unstructured":"Hart CE, Kraiss LW, Vergel S, Gilbertson D, Kenagy R, Kirkman T, Crandall DL, Tickle S, Finney H, Yarranton G et al (1999) PDGF\u03b2 receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 99(4):564\u2013569","journal-title":"Circulation"},{"issue":"5","key":"9484_CR57","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5414\/CPP46236","volume":"46","author":"T Hawthorne","year":"2008","unstructured":"Hawthorne T, Giot L, Blake L, Kuang B, Gerwien R, Smithson G, Hahne W, Mansfield T, Starling GC, Pochart P et al (2008) A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D. Int J Clin Pharmacol Ther 46(5):236\u2013244","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"9484_CR58","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"C-H Heldin","year":"1999","unstructured":"Heldin C-H, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79(4):1283\u20131316","journal-title":"Physiol Rev"},{"issue":"10","key":"9484_CR59","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"C-H Heldin","year":"2004","unstructured":"Heldin C-H, Rubin K, Pietras K, \u00d6stman A (2004) High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4(10):806\u2013813","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"9484_CR60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1476-5381.2009.00158.x","volume":"157","author":"M Hennenberg","year":"2009","unstructured":"Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T (2009) Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 157(2):258\u2013270","journal-title":"Br J Pharmacol"},{"key":"9484_CR61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2466-11-30","volume":"11","author":"JK Hennigs","year":"2011","unstructured":"Hennigs JK, Keller G, Baumann HJ, Honecker F, Kluge S, Bokemeyer C, Brummendorf TH, Klose H (2011) Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? BMC Pulm Med 11:30","journal-title":"BMC Pulm Med"},{"issue":"20","key":"9484_CR62","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1242\/dev.00721","volume":"130","author":"RV Hoch","year":"2003","unstructured":"Hoch RV, Soriano P (2003) Roles of PDGF in animal development. Development 130(20):4769\u20134784","journal-title":"Development"},{"issue":"10","key":"9484_CR63","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","volume":"127","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galie N, Gomez-Sanchez MA, Grimminger F, Grunig E, Hassoun PM et al (2013) Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study. Circulation 127(10):1128\u20131138","journal-title":"Circulation"},{"issue":"6","key":"9484_CR64","first-page":"470","volume":"19","author":"Q Huang","year":"1997","unstructured":"Huang Q, Sun R (1997) Changes of PDGF-\u03b1 and \u03b2 receptor gene expression in hypoxic rat pulmonary vessels. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 19(6):470\u2013473","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"3","key":"9484_CR65","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","volume":"11","author":"M Humbert","year":"1998","unstructured":"Humbert M, Monti G, Fartoukh M, Magnan A, Brenot F, Rain B, Capron F, Galanaud P, Duroux P, Simonneau G et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11(3):554\u2013559","journal-title":"Eur Respir J"},{"issue":"1","key":"9484_CR66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176(1):85\u201397","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"9484_CR67","doi-asserted-by":"crossref","first-page":"i52","DOI":"10.1136\/ard.2009.117119","volume":"69","author":"N Hunzelmann","year":"2010","unstructured":"Hunzelmann N, Brinckmann J (2010) What are the new milestones in the pathogenesis of systemic sclerosis? Ann Rheum Dis 69(Suppl 1):i52\u2013i56","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9484_CR68","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.2005.01.032","volume":"23","author":"GC Jayson","year":"2005","unstructured":"Jayson GC, Parker GJ, Mullamitha S, Valle JW, Saunders M, Broughton L, Lawrance J, Carrington B, Roberts C, Issa B et al (2005) Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab\u2019, leads to fluid accumulation and is associated with increased tumor vascularized volume. J Clin Oncol 23(5):973\u2013981","journal-title":"J Clin Oncol"},{"issue":"4","key":"9484_CR69","doi-asserted-by":"crossref","first-page":"c312","DOI":"10.1159\/000319885","volume":"117","author":"KD Jhaveri","year":"2011","unstructured":"Jhaveri KD, Flombaum CD, Kroog G, Glezerman IG (2011) Nephrotoxicities associated with the use of tyrosine kinase inhibitors: a single-center experience and review of the literature. Nephron Clin Pract 117(4):c312\u2013c319","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"9484_CR70","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.175.5.1413","volume":"175","author":"RJ Johnson","year":"1992","unstructured":"Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175(5):1413\u20131416","journal-title":"J Exp Med"},{"issue":"16","key":"9484_CR71","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1242\/dev.127.16.3457","volume":"127","author":"L Karlsson","year":"2000","unstructured":"Karlsson L, Lindahl P, Heath JK, Betsholtz C (2000) Abnormal gastrointestinal development in PDGF-A and PDGFR-\u03b1 deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development 127(16):3457\u20133466","journal-title":"Development"},{"issue":"2 Pt 1","key":"9484_CR72","first-page":"L100","volume":"264","author":"D Katayose","year":"1993","unstructured":"Katayose D, Ohe M, Yamauchi K, Ogata M, Shirato K, Fujita H, Shibahara S, Takishima T (1993) Increased expression of PDGF A- and B-chain genes in rat lungs with hypoxic pulmonary hypertension. Am J Physiol 264(2 Pt 1):L100\u2013L106","journal-title":"Am J Physiol"},{"issue":"6","key":"9484_CR73","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/art.34354","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian N, Servettaz A, Marut W, Nicco C, Chereau C, Weill B, Batteux F (2012) Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor beta in the skin of mice with scleroderma-like features and prevents the development of the disease. Arthritis Rheum 64(6):1990\u20132000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9484_CR74","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.1019443108","volume":"108","author":"AR Keramati","year":"2011","unstructured":"Keramati AR, Singh R, Lin A, Faramarzi S, Ye ZJ, Mane S, Tellides G, Lifton RP, Mani A (2011) Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 108(5):1914\u20131918","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9484_CR75","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","volume":"12","author":"R Kerkela","year":"2006","unstructured":"Kerkela R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ et al (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12(8):908\u2013916","journal-title":"Nat Med"},{"issue":"2","key":"9484_CR76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/156800912799095144","volume":"12","author":"SA Kono","year":"2012","unstructured":"Kono SA, Heasley LE, Doebele RC, Camidge DR (2012) Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer. Curr Cancer Drug Targets 12(2):107\u2013123","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"9484_CR77","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/s10165-010-0310-x","volume":"20","author":"K Kurasawa","year":"2010","unstructured":"Kurasawa K, Arai S, Owada T, Maezawa R, Kumano K, Fukuda T (2010) Autoantibodies against platelet-derived growth factor receptor \u03b1 in patients with systemic lupus erythematosus. Mod Rheumatol 20(5):458\u2013465","journal-title":"Mod Rheumatol"},{"issue":"4","key":"9484_CR78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1165\/rcmb.2005-0004OC","volume":"33","author":"MC Lanner","year":"2005","unstructured":"Lanner MC, Raper M, Pratt WM, Rhoades RA (2005) Heterotrimeric G proteins and the platelet-derived growth factor receptor-\u03b2 contribute to hypoxic proliferation of smooth muscle cells. Am J Respir Cell Mol Biol 33(4):412\u2013419","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"9484_CR79","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1525-1470.2010.01301.x","volume":"28","author":"J Lazar","year":"2011","unstructured":"Lazar J, Poonawalla T, Teng JM (2011) A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy. Pediatr Dermatol 28(2):172\u2013175","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"9484_CR80","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.exer.2009.11.003","volume":"90","author":"H Lei","year":"2010","unstructured":"Lei H, Rheaume MA, Kazlauskas A (2010) Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp Eye Res 90(3):376\u2013381","journal-title":"Exp Eye Res"},{"issue":"9","key":"9484_CR81","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/MCB.01321-10","volume":"31","author":"H Lei","year":"2011","unstructured":"Lei H, Velez G, Kazlauskas A (2011) Pathological signaling via platelet-derived growth factor receptor \u03b1 involves chronic activation of Akt and suppression of p53. Mol Cell Biol 31(9):1788\u20131799","journal-title":"Mol Cell Biol"},{"issue":"9","key":"9484_CR82","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1021\/bi9919192","volume":"39","author":"O Lepp\u00e4nen","year":"2000","unstructured":"Lepp\u00e4nen O, Miyazawa K, B\u00e4ckstr\u00f6m G, Pietras K, Sj\u00f6blom T, Heldin C-H, \u00d6stman A (2000) Predimerization of recombinant platelet-derived growth factor receptor extracellular domains increases antagonistic potency. Biochemistry 39(9):2370\u20132375","journal-title":"Biochemistry"},{"issue":"16","key":"9484_CR83","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1101\/gad.8.16.1875","volume":"8","author":"P Lev\u00e9en","year":"1994","unstructured":"Lev\u00e9en P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C (1994) Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8(16):1875\u20131887","journal-title":"Genes Dev"},{"issue":"6","key":"9484_CR84","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/09537100120071013","volume":"12","author":"CD Lewis","year":"2001","unstructured":"Lewis CD, Olson NE, Raines EW, Reidy MA, Jackson CL (2001) Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets 12(6):352\u2013358","journal-title":"Platelets"},{"key":"9484_CR85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1748-717X-4-66","volume":"4","author":"M Li","year":"2009","unstructured":"Li M, Abdollahi A, Grone HJ, Lipson KE, Belka C, Huber PE (2009) Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat Oncol 4:66","journal-title":"Radiat Oncol"},{"issue":"10","key":"9484_CR86","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","volume":"10","author":"V Liakouli","year":"2011","unstructured":"Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10(10):590\u2013594","journal-title":"Autoimmun Rev"},{"issue":"1","key":"9484_CR87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1172\/JCI39942","volume":"120","author":"CH Liao","year":"2010","unstructured":"Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P et al (2010) Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120(1):242\u2013253","journal-title":"J Clin Invest"},{"issue":"6","key":"9484_CR88","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin SL, Kisseleva T, Brenner DA, Duffield JS (2008) Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173(6):1617\u20131627","journal-title":"Am J Pathol"},{"issue":"5323","key":"9484_CR89","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","volume":"277","author":"P Lindahl","year":"1997","unstructured":"Lindahl P, Johansson BR, Lev\u00e9en P, Betsholtz C (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277(5323):242\u2013245","journal-title":"Science"},{"issue":"3","key":"9484_CR90","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","volume":"55","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T (2011) Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 55(3):612\u2013625","journal-title":"J Hepatol"},{"issue":"1","key":"9484_CR91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ajg.2008.41","volume":"104","author":"L Llanos","year":"2009","unstructured":"Llanos L, Bellot P, Zapater P, Perez-Mateo M, Such J (2009) Acute hepatitis in a patient with cirrhosis and hepatocellular carcinoma treated with sorafenib. Am J Gastroenterol 104(1):257\u2013258","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"9484_CR92","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.24365","volume":"60","author":"N Loizos","year":"2009","unstructured":"Loizos N, Lariccia L, Weiner J, Griffith H, Boin F, Hummers L, Wigley F, Kussie P (2009) Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 60(4):1145\u20131151","journal-title":"Arthritis Rheum"},{"issue":"27","key":"9484_CR93","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","volume":"47","author":"LJ Lombardo","year":"2004","unstructured":"Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, Castaneda S, Cornelius LA, Das J, Doweyko AM et al (2004) Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 47(27):6658\u20136661","journal-title":"J Med Chem"},{"issue":"10","key":"9484_CR94","first-page":"1876","volume":"22","author":"A Ludwicka","year":"1995","unstructured":"Ludwicka A, Ohba T, Trojanowska M, Yamakage A, Strange C, Smith EA, Leroy EC, Sutherland S, Silver RM (1995) Elevated levels of platelet derived growth factor and transforming growth factor-\u03b21 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 22(10):1876\u20131883","journal-title":"J Rheumatol"},{"issue":"6","key":"9484_CR95","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ana.22549","volume":"70","author":"Q Ma","year":"2011","unstructured":"Ma Q, Huang B, Khatibi N, Rolland W 2nd, Suzuki H, Zhang JH, Tang J (2011) PDGFR-\u03b1 inhibition preserves blood\u2013brain barrier after intracerebral hemorrhage. Ann Neurol 70(6):920\u2013931","journal-title":"Ann Neurol"},{"issue":"2","key":"9484_CR96","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/STROKEAHA.108.530196","volume":"40","author":"Y Maeda","year":"2009","unstructured":"Maeda Y, Hirano K, Hirano M, Kikkawa Y, Kameda K, Sasaki T, Kanaide H (2009) Enhanced contractile response of the basilar artery to platelet-derived growth factor in subarachnoid hemorrhage. Stroke 40(2):591\u2013596","journal-title":"Stroke"},{"issue":"5816","key":"9484_CR97","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","volume":"315","author":"A Mani","year":"2007","unstructured":"Mani A, Radhakrishnan J, Wang H, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315(5816):1278\u20131282","journal-title":"Science"},{"issue":"1","key":"9484_CR98","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajpath.2012.09.006","volume":"182","author":"IV Martin","year":"2013","unstructured":"Martin IV, Borkham-Kamphorst E, Zok S, van Roeyen CR, Eriksson U, Boor P, Hittatiya K, Fischer HP, Wasmuth HE, Weiskirchen R et al (2013) Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. Am J Pathol 182(1):107\u2013117","journal-title":"Am J Pathol"},{"issue":"12","key":"9484_CR99","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/bmt.2008.415","volume":"43","author":"D Mattei","year":"2009","unstructured":"Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A (2009) Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient. Bone Marrow Transplant 43(12):967\u2013968","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"9484_CR100","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","volume":"71","author":"B Maurer","year":"2012","unstructured":"Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, Michel BA, Gay S, Distler JH, Distler O (2012) Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. Ann Rheum Dis 71(8):1382\u20131387","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9484_CR101","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","volume":"49","author":"M Mejias","year":"2009","unstructured":"Mejias M, Garcia-Pras E, Tiani C, Miquel R, Bosch J, Fernandez M (2009) Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats. Hepatology 49(4):1245\u20131256","journal-title":"Hepatology"},{"issue":"3","key":"9484_CR102","doi-asserted-by":"crossref","first-page":"e18004","DOI":"10.1371\/journal.pone.0018004","volume":"6","author":"PT Nguyen","year":"2011","unstructured":"Nguyen PT, Nakamura T, Hori E, Urakawa S, Uwano T, Zhao J, Li R, Bac ND, Hamashima T, Ishii Y et al (2011) Cognitive and socio-emotional deficits in platelet-derived growth factor receptor-\u03b2 gene knockout mice. PLoS One 6(3):e18004","journal-title":"PLoS One"},{"issue":"11","key":"9484_CR103","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1872-034X.2010.00718.x","volume":"40","author":"S Ogawa","year":"2010","unstructured":"Ogawa S, Ochi T, Shimada H, Inagaki K, Fujita I, Nii A, Moffat MA, Katragadda M, Violand BN, Arch RH et al (2010) Anti-PDGF-B monoclonal antibody reduces liver fibrosis development. Hepatol Res 40(11):1128\u20131141","journal-title":"Hepatol Res"},{"issue":"6","key":"9484_CR104","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.devcel.2011.04.019","volume":"20","author":"LE Olson","year":"2011","unstructured":"Olson LE, Soriano P (2011) PDGFR\u03b2 signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 20(6):815\u2013826","journal-title":"Dev Cell"},{"issue":"7","key":"9484_CR105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-011-1892-z","volume":"27","author":"T Ostendorf","year":"2012","unstructured":"Ostendorf T, Eitner F, Floege J (2012) The PDGF family in renal fibrosis. Pediatr Nephrol 27(7):1041\u20131050","journal-title":"Pediatr Nephrol"},{"key":"9484_CR106","volume-title":"Molecular oncology: Causes of cancer and targets for treatment","author":"A \u00d6stman","year":"2013","unstructured":"\u00d6stman A, Heldin C-H (2013) Platelet-derived growth factor. In: Gelmann E, Sawers C, Rauscher F III (eds) Molecular oncology: Causes of cancer and targets for treatment. Cambridge University Press, Cambridge, in press"},{"issue":"2","key":"9484_CR107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-145-2-200607180-00020","volume":"145","author":"KC Patterson","year":"2006","unstructured":"Patterson KC, Weissmann A, Ahmadi T, Farber HW (2006) Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 145(2):152\u2013153","journal-title":"Ann Intern Med"},{"issue":"28","key":"9484_CR108","doi-asserted-by":"crossref","first-page":"21615","DOI":"10.1074\/jbc.M110.107003","volume":"285","author":"F Peng","year":"2010","unstructured":"Peng F, Yao H, Bai X, Zhu X, Reiner BC, Beazely M, Funa K, Xiong H, Buch S (2010) Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc\/Arg3.1. J Biol Chem 285(28):21615\u201321624","journal-title":"J Biol Chem"},{"issue":"1","key":"9484_CR109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","volume":"178","author":"F Perros","year":"2008","unstructured":"Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O et al (2008) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81\u201388","journal-title":"Am J Respir Crit Care Med"},{"key":"9484_CR110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1535-6108(03)00089-8","volume":"3","author":"K Pietras","year":"2003","unstructured":"Pietras K, Sj\u00f6blom T, Rubin K, Heldin C-H, \u00d6stman A (2003) PDGF receptors as cancer drug targets. Cancer Cell 3:439\u2013443","journal-title":"Cancer Cell"},{"issue":"1","key":"9484_CR111","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2036.2011.04896.x","volume":"35","author":"M Pinter","year":"2012","unstructured":"Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M (2012) The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma\u2013a pilot study. Aliment Pharmacol Ther 35(1):83\u201391","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"9484_CR112","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9440(10)63694-2","volume":"163","author":"A Pont\u00e9n","year":"2003","unstructured":"Pont\u00e9n A, Li X, Thor\u00e9n P, Aase K, Sj\u00f6blom T, \u00d6stman A, Eriksson U (2003) Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol 163(2):673\u2013682","journal-title":"Am J Pathol"},{"issue":"10","key":"9484_CR113","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.RES.0000190590.31545.d4","volume":"97","author":"A Pont\u00e9n","year":"2005","unstructured":"Pont\u00e9n A, Folestad EB, Pietras K, Eriksson U (2005) Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice. Circ Res 97(10):1036\u20131045","journal-title":"Circ Res"},{"issue":"6","key":"9484_CR114","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/ATVBAHA.112.248500","volume":"32","author":"SS Pullamsetti","year":"2012","unstructured":"Pullamsetti SS, Berghausen EM, Dabral S, Tretyn A, Butrous E, Savai R, Butrous G, Dahal BK, Brandes RP, Ghofrani HA et al (2012) Role of Src tyrosine kinases in experimental pulmonary hypertension. Arterioscler Thromb Vasc Biol 32(6):1354\u20131365","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"9484_CR115","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1200\/JCO.2007.12.0329","volume":"25","author":"A Quintas-Cardama","year":"2007","unstructured":"Quintas-Cardama A, Kantarjian H, O\u2019Brien S, Borthakur G, Bruzzi J, Munden R, Cortes J (2007) Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol 25(25):3908\u20133914","journal-title":"J Clin Oncol"},{"issue":"4","key":"9484_CR116","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cytogfr.2004.03.004","volume":"15","author":"EW Raines","year":"2004","unstructured":"Raines EW (2004) PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15(4):237\u2013254","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"9484_CR117","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2009.06.024","volume":"51","author":"T Reiberger","year":"2009","unstructured":"Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M (2009) Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. J Hepatol 51(5):865\u2013873","journal-title":"J Hepatol"},{"issue":"3","key":"9484_CR118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000327719","volume":"82","author":"CK Rhee","year":"2011","unstructured":"Rhee CK, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, Kim YK, Kim KH, Kim TJ, Kim JW (2011) Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. Respiration 82(3):273\u2013287","journal-title":"Respiration"},{"issue":"1","key":"9484_CR119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0002-9440(10)65115-2","volume":"155","author":"AB Rice","year":"1999","unstructured":"Rice AB, Moomaw CR, Morgan DL, Bonner JC (1999) Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 155(1):213\u2013221","journal-title":"Am J Pathol"},{"issue":"12","key":"9484_CR120","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","volume":"365","author":"L Richeldi","year":"2011","unstructured":"Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G et al (2011) Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365(12):1079\u20131087","journal-title":"N Engl J Med"},{"key":"9484_CR121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0140-6736(92)90143-Q","volume":"339","author":"MC Robson","year":"1992","unstructured":"Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF (1992) Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 339:23\u201325","journal-title":"Lancet"},{"issue":"1","key":"9484_CR122","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2012.10.072","volume":"226","author":"R Rodr\u00edguez-Gonz\u00e1lez","year":"2013","unstructured":"Rodr\u00edguez-Gonz\u00e1lez R, Blanco M, Rodr\u00edguez-Y\u00e1\u00f1ez M, Moldes O, Castillo J, Sobrino T (2013) Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator. Atherosclerosis 226(1):165\u2013171","journal-title":"Atherosclerosis"},{"issue":"Pt 1","key":"9484_CR123","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1113\/jphysiol.1996.sp021584","volume":"495","author":"S\u00c5 Rodt","year":"1996","unstructured":"Rodt S\u00c5, \u00c5hl\u00e9n K, Berg A, Rubin K, Reed RK (1996) A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol 495(Pt 1):193\u2013200","journal-title":"J Physiol"},{"issue":"24","key":"9484_CR124","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1161\/01.CIR.103.24.2955","volume":"103","author":"H Sano","year":"2001","unstructured":"Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, Takakura N, Nishikawa S, Nishikawa SI, Kita T (2001) Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 103(24):2955\u20132960","journal-title":"Circulation"},{"issue":"10","key":"9484_CR125","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115(10):2811\u20132821","journal-title":"J Clin Invest"},{"issue":"8","key":"9484_CR126","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1572-0241.2008.01982_19.x","volume":"103","author":"C Schramm","year":"2008","unstructured":"Schramm C, Schuch G, Lohse AW (2008) Sorafenib-induced liver failure. Am J Gastroenterol 103(8):2162\u20132163","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"9484_CR127","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/rheumatology\/ken104","volume":"47","author":"PP Sfikakis","year":"2008","unstructured":"Sfikakis PP, Gorgoulis VG, Katsiari CG, Evangelou K, Kostopoulos C, Black CM (2008) Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) 47(5):735\u2013737","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"9484_CR128","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbrc.2007.04.075","volume":"357","author":"J Shen","year":"2007","unstructured":"Shen J, Vil MD, Zhang H, Tonra JR, Rong LL, Damoci C, Prewett M, Deevi DS, Kearney J, Surguladze D et al (2007) An antibody directed against PDGF receptor \u03b2 enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody. Biochem Biophys Res Commun 357(4):1142\u20131147","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9484_CR129","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1593\/neo.09278","volume":"11","author":"J Shen","year":"2009","unstructured":"Shen J, Vil MD, Prewett M, Damoci C, Zhang H, Li H, Jimenez X, Deevi DS, Iacolina M, Kayas A et al (2009) Development of a fully human anti-PDGFR\u03b2 antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody. Neoplasia 11(6):594\u2013604","journal-title":"Neoplasia"},{"issue":"1","key":"9484_CR130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2012.01.005","volume":"46","author":"M Shiba","year":"2012","unstructured":"Shiba M, Suzuki H, Fujimoto M, Shimojo N, Imanaka-Yoshida K, Yoshida T, Kanamaru K, Matsushima S, Taki W (2012) Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis 46(1):172\u2013179","journal-title":"Neurobiol Dis"},{"issue":"12","key":"9484_CR131","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/CIRCRESAHA.110.235531","volume":"108","author":"CL Smith","year":"2011","unstructured":"Smith CL, Baek ST, Sung CY, Tallquist MD (2011) Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ Res 108(12):e15\u2013e26","journal-title":"Circ Res"},{"issue":"2","key":"9484_CR132","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000111507","volume":"216","author":"A Soria","year":"2008","unstructured":"Soria A, Cario-Andre M, Lepreux S, Rezvani HR, Pasquet JM, Pain C, Schaeverbeke T, Mahon FX, Taieb A (2008) The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study. Dermatology 216(2):109\u2013117","journal-title":"Dermatology"},{"issue":"16","key":"9484_CR133","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1101\/gad.8.16.1888","volume":"8","author":"P Soriano","year":"1994","unstructured":"Soriano P (1994) Abnormal kidney development and hematological disorders in PDGF \u03b2-receptor mutant mice. Genes Dev 8(16):1888\u20131896","journal-title":"Genes Dev"},{"issue":"14","key":"9484_CR134","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1242\/dev.124.14.2691","volume":"124","author":"P Soriano","year":"1997","unstructured":"Soriano P (1997) The PDGF\u03b1 receptor is required for neural crest cell development and for normal patterning of the somites. Development 124(14):2691\u20132700","journal-title":"Development"},{"issue":"7211","key":"9484_CR135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature07209","volume":"455","author":"L Soroceanu","year":"2008","unstructured":"Soroceanu L, Akhavan A, Cobbs CS (2008) Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455(7211):391\u2013395","journal-title":"Nature"},{"issue":"8","key":"9484_CR136","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/thx.2006.064097","volume":"61","author":"R Souza","year":"2006","unstructured":"Souza R, Sitbon O, Parent F, Simonneau G, Humbert M (2006) Long term imatinib treatment in pulmonary arterial hypertension. Thorax 61(8):736","journal-title":"Thorax"},{"issue":"6","key":"9484_CR137","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ard.2010.143974","volume":"70","author":"RF Spiera","year":"2011","unstructured":"Spiera RF, Gordon JK, Mersten JN, Magro CM, Mehta M, Wildman HF, Kloiber S, Kirou KA, Lyman S, Crow MK (2011) Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial. Ann Rheum Dis 70(6):1003\u20131009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9484_CR138","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm1787","volume":"14","author":"EJ Su","year":"2008","unstructured":"Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M et al (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood\u2013brain barrier integrity during ischemic stroke. Nat Med 14(7):731\u2013737","journal-title":"Nat Med"},{"issue":"25","key":"9484_CR139","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","volume":"354","author":"S Svegliati Baroni","year":"2006","unstructured":"Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A et al (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354(25):2667\u20132676","journal-title":"N Engl J Med"},{"issue":"1","key":"9484_CR140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2007-01-071043","volume":"110","author":"S Svegliati","year":"2007","unstructured":"Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, Moroncini G, Bacigalupo A, Leoni P, Avvedimento EV et al (2007) Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 110(1):237\u2013241","journal-title":"Blood"},{"issue":"4","key":"9484_CR141","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00392-009-0752-3","volume":"98","author":"H ten Freyhaus","year":"2009","unstructured":"ten Freyhaus H, Dumitrescu D, Bovenschulte H, Erdmann E, Rosenkranz S (2009) Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension. Clin Res Cardiol 98(4):265\u2013267","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"9484_CR142","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.200911-1663OC","volume":"183","author":"H ten Freyhaus","year":"2011","unstructured":"ten Freyhaus H, Dagnell M, Leuchs M, Vantler M, Berghausen EM, Caglayan E, Weissmann N, Dahal BK, Schermuly RT, Ostman A et al (2011) Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases. Am J Respir Crit Care Med 183(8):1092\u20131102","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9484_CR143","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/13543784.2012.632408","volume":"21","author":"H ten Freyhaus","year":"2012","unstructured":"ten Freyhaus H, Dumitrescu D, Berghausen E, Vantler M, Caglayan E, Rosenkranz S (2012) Imatinib mesylate for the treatment of pulmonary arterial hypertension. Expert Opin Investig Drugs 21(1):119\u2013134","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"9484_CR144","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2008.05.022","volume":"423","author":"F Thieringer","year":"2008","unstructured":"Thieringer F, Maass T, Czochra P, Klopcic B, Conrad I, Friebe D, Schirmacher P, Lohse AW, Blessing M, Galle PR et al (2008) Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene 423(1):23\u201328","journal-title":"Gene"},{"issue":"10","key":"9484_CR145","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.transproceed.2006.10.056","volume":"38","author":"R Tuuminen","year":"2006","unstructured":"Tuuminen R, Nykanen A, Keranen MA, Krebs R, Alitalo K, Koskinen PK, Lemstrom KB (2006) The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis. Transplant Proc 38(10):3271\u20133273","journal-title":"Transplant Proc"},{"issue":"14","key":"9484_CR146","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1128\/MCB.25.14.6279-6288.2005","volume":"25","author":"CV Ustach","year":"2005","unstructured":"Ustach CV, Kim HR (2005) Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol Cell Biol 25(14):6279\u20136288","journal-title":"Mol Cell Biol"},{"issue":"23","key":"9484_CR147","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1158\/0008-5472.CAN-10-0511","volume":"70","author":"CV Ustach","year":"2010","unstructured":"Ustach CV, Huang W, Conley-LaComb MK, Lin CY, Che M, Abrams J, Kim HR (2010) A novel signaling axis of matriptase\/PDGF-D\/ss-PDGFR in human prostate cancer. Cancer Res 70(23):9631\u20139640","journal-title":"Cancer Res"},{"issue":"8","key":"9484_CR148","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/art.23648","volume":"58","author":"PL van Daele","year":"2008","unstructured":"van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, van Hagen PM (2008) Is imatinib mesylate a promising drug in systemic sclerosis? Arthritis Rheum 58(8):2549\u20132552","journal-title":"Arthritis Rheum"},{"issue":"12","key":"9484_CR149","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ki.2011.278","volume":"80","author":"CR van Roeyen","year":"2011","unstructured":"van Roeyen CR, Eitner F, Boor P, Moeller MJ, Raffetseder U, Hanssen L, Bucher E, Villa L, Banas MC, Hudkins KL et al (2011) Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D. Kidney Int 80(12):1292\u20131305","journal-title":"Kidney Int"},{"issue":"1","key":"9484_CR150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","volume":"53","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H (2010) New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol 53(1):132\u2013144","journal-title":"J Hepatol"},{"issue":"6","key":"9484_CR151","doi-asserted-by":"crossref","first-page":"e21707","DOI":"10.1371\/journal.pone.0021707","volume":"6","author":"H Wen","year":"2011","unstructured":"Wen H, Lu Y, Yao H, Buch S (2011) Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability. PLoS One 6(6):e21707","journal-title":"PLoS One"},{"issue":"2","key":"9484_CR152","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mcn.2003.10.014","volume":"25","author":"RH Woodruff","year":"2004","unstructured":"Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ (2004) Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25(2):252\u2013262","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"9484_CR153","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.RES.88.6.630","volume":"88","author":"Y Yamasaki","year":"2001","unstructured":"Yamasaki Y, Miyoshi K, Oda N, Watanabe M, Miyake H, Chan J, Wang X, Sun L, Tang C, McMahon G et al (2001) Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis. Circ Res 88(6):630\u2013636","journal-title":"Circ Res"},{"issue":"8","key":"9484_CR154","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1182\/blood-2010-10-313593","volume":"117","author":"H Yao","year":"2011","unstructured":"Yao H, Duan M, Buch S (2011) Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 117(8):2538\u20132547","journal-title":"Blood"},{"issue":"4","key":"9484_CR155","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1227\/01.NEU.0000366111.08024.26","volume":"66","author":"ZW Zhang","year":"2010","unstructured":"Zhang ZW, Yanamoto H, Nagata I, Miyamoto S, Nakajo Y, Xue JH, Iihara K, Kikuchi H (2010) Platelet-derived growth factor-induced severe and chronic vasoconstriction of cerebral arteries: proposed growth factor explanation of cerebral vasospasm. Neurosurgery 66(4):728\u2013735","journal-title":"Neurosurgery"},{"issue":"11","key":"9484_CR156","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jacc.2005.07.060","volume":"46","author":"D Zohlnh\u00f6fer","year":"2005","unstructured":"Zohlnh\u00f6fer D, Hausleiter J, Kastrati A, Mehilli J, Goos C, Sch\u00fchlen H, Pache J, Pogatsa-Murray G, Heemann U, Dirschinger J et al (2005) A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib. J Am Coll Cardiol 46(11):1999\u20132003","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-013-9484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11481-013-9484-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-013-9484-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-013-9484-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T14:44:38Z","timestamp":1688309078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11481-013-9484-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,25]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9484"],"URL":"https:\/\/doi.org\/10.1007\/s11481-013-9484-2","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,25]]},"assertion":[{"value":"24 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}